Exchange: NASDAQ·Updated 07:30 PM EST
ERAS logo

ERAS Erasca Inc

$13.74
$0.61
(4.29%)
Today
Closed $13.61
$0.13
(0.95%)
After Hours
Reported EarningsNov 12
Mkt Cap$4.78B
Vol11.07M

About ERAS

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on July 2, 2018 and is headquartered in San Diego, CA.
79

Extremely Bullish Sentiment

How do you feel about ERAS?

EmSol
$ERAS buy now and wait 18 months, phase 1 was great need confirm with more patient, it maybe BO during next 12 months , $RVMD relax enjoys the ride, no competitor until 2029-2030 approval USA Europe, China coming next month, other country will follow, Target $300 and start to sale
1
biolover
$ERAS will end day green. Could be big green. It will steadily march up next few days even in this market.
1
Rayvio_News_Filter
$ERAS 🏥 Erasca, Inc. reported Phase 1 data for ERAS-0015 showing 44% confirmed ORR in 2L+ KRAS G12X PDAC, 69% in KRAS G12D or G12V PDAC, and 60% in post-ICI/platinum KRAS G12X NSCLC at 32 mg QD, with generally well-tolerated safety. Market-relevant event
1
FlashSigma
$ERAS quietly holding attention here. Not a ton of noise but the chart action says someone's paying attention. Feels like a wait-and-see setup right now. Watching how it behaves around current levels before reading too much into it.
1
PhishTourFunds
$ERAS Better than 2x daily average volume here today ~ shorts are absolutely loaded to the gills 👀
1
red_bull7
$ERAS Expecting a nice run up with Fast Tracked Cancer Drug Data readout later this month. $SPY $RVMD $BBOT
1
EmSol
$ERAS no need to attack me, I don’t say it’s bad I just say let’s wait it’s only phase 1 and not lot of patients, I’m very happy for your wife, this why I believe in science, my point is just $RVMD stay tge only one drug for the next 3-4 years but sure $ERAS is a good investment today and I own 3000 shares. I’m bull but wait and see more data with larger population
shoc24
$ERAS reported earnings after the close today. GAAP EPS missed estimates: -$0.15 vs. -$0.13 expected, according to Stock Meadow.

Advertisement|Remove ads.